An Open Label Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy
Latest Information Update: 06 Nov 2021
At a glance
- Drugs Eptacog alfa (Primary)
- Indications Haemorrhagic cystitis
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 14 Apr 2015 New trial record